TYRATyra Biosciences, Inc.

Nasdaq tyra.bio


$ 20.98 $ -0.10 (-0.47 %)    

Monday, 09-Sep-2024 10:46:21 EDT
QQQ $ 451.41 $ -1.12 (-0.25 %)
DIA $ 408.32 $ 0.99 (0.24 %)
SPY $ 543.97 $ -0.70 (-0.13 %)
TLT $ 99.78 $ 0.40 (0.4 %)
GLD $ 230.71 $ -0.54 (-0.24 %)
$ 20.59
$ 21.08
$ 21.05 x 100
$ 24.00 x 208
$ 20.67 - $ 21.20
$ 10.38 - $ 24.25
66,986
na
1.09B
$ 2.37
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-07-2024 06-30-2024 10-Q
2 05-09-2024 03-31-2024 10-Q
3 03-19-2024 12-31-2023 10-K
4 11-07-2023 09-30-2023 10-Q
5 08-10-2023 06-30-2023 10-Q
6 05-04-2023 03-31-2023 10-Q
7 03-22-2023 12-31-2022 10-K
8 11-03-2022 09-30-2022 10-Q
9 08-04-2022 06-30-2022 10-Q
10 05-05-2022 03-31-2022 10-Q
11 03-03-2022 12-31-2021 10-K
12 11-03-2021 09-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 piper-sandler-initiates-coverage-on-tyra-biosciences-with-overweight-rating-announces-price-target-of-33

Piper Sandler analyst Christopher Raymond initiates coverage on Tyra Biosciences (NASDAQ:TYRA) with a Overweight rating and ...

 wedbush-reiterates-outperform-on-tyra-biosciences-maintains-28-price-target

Wedbush analyst Robert Driscoll reiterates Tyra Biosciences (NASDAQ:TYRA) with a Outperform and maintains $28 price target.

 oppenheimer-maintains-outperform-on-tyra-biosciences-lowers-price-target-to-25

Oppenheimer analyst Matthew Biegler maintains Tyra Biosciences (NASDAQ:TYRA) with a Outperform and lowers the price target f...

 tyra-biosciences-q2-eps-032-beats-041-estimate

Tyra Biosciences (NASDAQ:TYRA) reported quarterly losses of $(0.32) per share which beat the analyst consensus estimate of $(0....

 oppenheimer-reiterates-outperform-on-tyra-biosciences-maintains-28-price-target

Oppenheimer analyst Matthew Biegler reiterates Tyra Biosciences (NASDAQ:TYRA) with a Outperform and maintains $28 price target.

 wedbush-reiterates-outperform-on-tyra-biosciences-maintains-28-price-target

Wedbush analyst Robert Driscoll reiterates Tyra Biosciences (NASDAQ:TYRA) with a Outperform and maintains $28 price target.

 hc-wainwright--co-reiterates-buy-on-tyra-biosciences-maintains-23-price-target

HC Wainwright & Co. analyst Mitchell Kapoor reiterates Tyra Biosciences (NASDAQ:TYRA) with a Buy and maintains $23 price...

 hc-wainwright--co-reiterates-buy-on-tyra-biosciences-maintains-23-price-target

HC Wainwright & Co. analyst Mitchell Kapoor reiterates Tyra Biosciences (NASDAQ:TYRA) with a Buy and maintains $23 price...

 oppenheimer-reiterates-outperform-on-tyra-biosciences-raises-price-target-to-28

Oppenheimer analyst Matthew Biegler reiterates Tyra Biosciences (NASDAQ:TYRA) with a Outperform and raises the price target ...

 wedbush-reiterates-outperform-on-tyra-biosciences-maintains-28-price-target

Wedbush analyst Robert Driscoll reiterates Tyra Biosciences (NASDAQ:TYRA) with a Outperform and maintains $28 price target.

 hc-wainwright--co-reiterates-buy-on-tyra-biosciences-maintains-23-price-target

HC Wainwright & Co. analyst Mitchell Kapoor reiterates Tyra Biosciences (NASDAQ:TYRA) with a Buy and maintains $23 price...

 tyra-biosciences-q1-2024-adj-eps-035-beats-046-estimate

Tyra Biosciences (NASDAQ:TYRA) reported quarterly losses of $(0.35) per share which beat the analyst consensus estimate of $(0....

 wedbush-reiterates-outperform-on-tyra-biosciences-maintains-28-price-target

Wedbush analyst Robert Driscoll reiterates Tyra Biosciences (NASDAQ:TYRA) with a Outperform and maintains $28 price target.

 hc-wainwright--co-reiterates-buy-on-tyra-biosciences-raises-price-target-to-23

HC Wainwright & Co. analyst Mitchell Kapoor reiterates Tyra Biosciences (NASDAQ:TYRA) with a Buy and raises the price ta...

 tyra-biosciences-inc-files-for-resale-of-up-to-154m-shares-by-the-selling-securityholders

- SEC Filing

 tyra-biosciences-q4-eps-053-misses-048-estimate

Tyra Biosciences (NASDAQ:TYRA) reported quarterly losses of $(0.53) per share which missed the analyst consensus estimate of $(...

 sp-500-gains-over-1-amazon-earnings-top-expectations

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 1.8% on Friday. The Dow traded u...

 why-skechers-shares-are-trading-lower-by-around-7-here-are-other-stocks-moving-in-fridays-mid-day-session

Shares of Skechers U.S.A., Inc. (NYSE: SKX) shares fell during Friday’s session after the company reported mixed fourth-quarte...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION